Quick facts
The primary cause of DCM is understood to be genetic, leading to a focus on tailoring treatments based on the specific molecular origin. Genetic testing plays a crucial role in DCM, as numerous studies and case reports have demonstrated, serving as a vital tool for diagnosis, prognosis, familial screening, and reproductive decision-making.
As an alternative to oral small-molecule therapies for DCM associated with mutations in different sarcomere-related genes, new therapies are emerging that involve stem cell transplantation and gene editing techniques. These innovative treatments focus on targeting specific gene variants that affect sarcomeric and ...
